|
Register
now for this premier event!
|
Sessions
Include |
| Track 1: Bridging Discovery and IT |
- Developing Drug Discovery Strategies that Leverage New
Technology
- Integrating Biology, Chemistry, and Drug Safety
- Extracting Maximum Value from Informatics
- Identifying Strategic Shifts in Information Technology Investments
- Overcoming Cultural and “Language” Barriers
|
| Track 2: Bridging Development and IT |
- In silico Approaches for Predicting
Drug Properties
- Validation of ADME/Tox Models
- Integration of Diverse IT Databases
- Early Development System Requirements and
Capabilities
- Improving the Interface Between IT Specialists and Assay Designers -
Getting the Data Needed
|
| Track 3: Bridging Clinical and IT |
- Capturing, Managing and Measuring Clinical Data Quality to Ensure
Accurate Statistical Analysis and Optimum Outcomes
- Progress on Standards and Interoperability
- Adapting Clinical Trial Operations in Tandem with EDC
Technologies
and Implementation
- Using IT for Continuous Process Managing, Improvement, and Innovation to Increase Productivity and ROI
- Choosing Strategies for Global Trials
|
|
|
Pre-Conference
Tutorial - September 25, 2006
Successful Project Management Methods and Approaches to Improve Cross Multi-Disciplinary Teams and Deliver
Value on Time
Thomas Haskell, VP, Pharmaceutical Solutions, Idea
Integration
Brian Kerrigan, Senior Program Director, Idea Integration
|
| |
|
The 2006 Bridging Pharma and IT program will focus on tactics and processes that
organizations can effectively and efficiently use to minimize communication gaps
between scientists, researchers, and information technology professionals in building
solutions and capabilities, utilizing data models and their validation, and integrating
drug targets and compounds. This program will feature compelling examples of successful
cross-domain partnerships between the organization’s end users and IT and
insights into cutting-edge information tools and systems.
|
|
|
Keynote
Presentations |
|
Blurring the Boundaries: Bridging Technology with
Discovery, Development and Clinical |
|
Dr. Gerhard Noelken, Director Research Informatics, Research Informatics, Pfizer Global R&D
|
| Use of Modeling and Simulation from Preclinical
to Commercial Stages: Case Study in Therapeutic Development |
|
|
Serge Guzy, PhD, Senior Scientist II, XOMA |
|
Kathleen Meyer, MPH, PhD, DABT, Director, Toxicology, XOMA |
|
|
|
| In-housing the Outsource: Rapid Co-Evolution of
a Discovery-Computational Team to Drive Innovation |
|
|
Michael Hanley, PhD,Vice President
of Discovery Research, Amylin, Inc. |
|
|
Robert D. Feinstein,PhD, VP &
CSO, Kelaroo, Inc. |
|
|
|
|
How Clinical Data Feeds Back into the
Discovery and Development Process
Anastasia M. Khoury Christianson, PhD, Director and Global Skill Leader,
Discovery Medicine Informatics,
AstraZeneca R&D
|
|
|
Democratizing the Discovery Process
|
 |
Don Rule, MBA, Platform Strategy Advisor for
Bioinformatics, Microsoft Corporation
|
|
|
|
|
|
Look for
this logo
to identify these joint
case studies.
|
|
|
Look for
this logo
to identify these unique
position case studies.
|
|
Presentations from:
Allergan, Inc., Amylin, Inc., Eli Lilly and Co., Forest Research Inst., Johnson & Johnson
Kelaroo, Inc., Merck & Co., Inc., Microsoft Corporation, Millennium Pharmaceuticals, Inc.
Odyssey Thera, Inc., Oracle, Penn State Cance, Institute/Penn State University,
Pfizer, Inc.
Roche Laboratories, Wyeth Research, XOMA, LLC and more!
|
Pairing Discount
50% off 2nd team member registration
Paired Team from Same Company =1 science end user + IT counterpart
|
For more information, please contact:
Cindy Crowninshield, Conference Director,
Pharmaceutical Strategy Series, Cambridge Healthtech Institute
Phone: 781-354-0120; Email: ccrowninshield@pharmaseries.com
For sponsorship or exhibiting information, please contact:
Laura Ames, Cambridge Healthtech Institute
Phone: 781-972-5479
Email: lames@healthech.com
|
